September 19, 2012, 6:08 PM UTC

Alllianz Capital Partners and 3i Group are planning a 2013 sale of Baltic ferry group Scandlines, according to The Irish Times. The firms, which each hold a 50% stake of Scandlines, are hoping to fetch upwards of €1.4 billion. www.scandlines.se

Apax Partners
 has received “tentative bids: for German direct marketing company LR Health & Beauty, according to Reuters. UBS and Societe Generale are managing the process, with Commerzbank, DZ Bank and Societe Generale among the banks trying to put together a financing package. www.apax.com

B2Gold Corp. (TSX: BTO) of Canada has agreed to acquire Australia-based CGA Mining Ltd. (ASX: CGX) for approximately C$1.1 billion, or C$3.18 per share (20% premium to yesterday’s closing price).www.cgamining.com

Cypress Semiconductor Corp. (Nasdaq: CY) has agreed to acquire memory chipmaker Ramtron International Corp. (Nasdaq: RMTR) for approximately $109.8 million, or $3.10 per Ramtron share (71% premium to June 11, the day before Cypress announced its offer for Ramtron). www.cypress.com

Syngenta has agreed to acquire Pasteuria Bioscience Inc., an Alachua, Fla.-based developer of biological nematicides. The deal is worth upwards of $113 million, including an $86 million up-front payment. Pasteuria backers include Advantage Capital Partners, Florida Gulfshore Capital, Gordon River Capital and Life Sciences Partners. www.syngenta.com

Sign up for Dan’s daily email newsletter on deals and deal-makers: GetTermSheet.com